MK-3903

CAS No. 1219737-12-8

MK-3903 ( MK3903 )

Catalog No. M10828 CAS No. 1219737-12-8

MK-3903 is a potent and selective, direct and oral AMPK activator with EC50 of 9 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 48 In Stock
5MG 87 In Stock
10MG 160 In Stock
25MG 296 In Stock
50MG 478 In Stock
100MG 691 In Stock
500MG 1422 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MK-3903
  • Note
    Research use only, not for human use.
  • Brief Description
    MK-3903 is a potent and selective, direct and oral AMPK activator with EC50 of 9 nM.
  • Description
    MK-3903 is a potent and selective, direct and oral AMPK activator with EC50 of 9 nM; activates 10 of the 12 phosphorylated AMPK (pAMPK) complexes with EC50s of 8-40 nM, improves lipid metabolism and insulin sensitization in mice.
  • Synonyms
    MK3903
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    AMPK
  • Recptor
    AMPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1219737-12-8
  • Formula Weight
    454.91
  • Molecular Formula
    C27H19ClN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 70 mg/mL; Water: Insoluble; Ethanol: Insoluble ( < 1 mg/ml refers to the product slightly soluble or insoluble )
  • SMILES
    CC1=C(C=C(C=C1)OC2=NC3=C(N2)C=C(C(=C3)C4=CC=C(C=C4)C5=CC=CC=C5)Cl)C(=O)O
  • Chemical Name
    5-[(5-[1,1'-Biphenyl]-4-yl-6-chloro-1H-benzimidazol-2-yl)oxy]-2-methylbenzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lan P, et al. J Med Chem. 2017 Nov 9;60(21):9040-9052.
molnova catalog
related products
  • Kudinoside D

    Kudinoside D exerts anti-adipogenic effects through modulation of adipogenic transcription factors via AMPK signaling pathway.

  • EX-229

    A small molecule AMPK activator that dose-dependently increases AMPK activity.

  • XMD-17-51 Trifluoroa...

    XMD-17-51 Trifluoroacetate is a potent and highly selective NUAK1 inhibitor.